483
Contract Pharmaceuticals Limited CanadaFDA 483 - Contract Pharmaceuticals Limited Canada - November 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Contract Pharmaceuticals Limited Canada in Mississauga, Canada, revealed a significant lapse in quality control procedures. The firm failed to thoroughly investigate the recovery of a highly pathogenic microorganism, Brucella melitensis, during environmental monitoring of a production area. This indicates a serious deficiency in their incident reporting and investigation processes, potentially compromising product safety.
Open in Dashboard
ID · e213dada-8783-40f0-9055-9b6e148e8c4d